5 amino 1mq safety toxicity study 5-Amino-1MQ 50MG Peptide 5-Amino-1MQ
Description
Protocols, doses, and reactions reported below come from published research and self-reported community sources
PMC8337113
5-Amino-1MQ: Next-Generation NNMT Inhibitor for Metabolic Research
Exact dosing varies by experimental design and species but generally follows preclinical trial standards for NNMT inhibitors
Reported Research Benefits Used in preclinical research focused on obesity, metabolic syndrome, diabetes, aging-related metabolic decline, fat mass reduction, and muscle preservation during caloric deficit
The mislabel does not change what the compound does
